Cardiovascular drugs market covers the drugs used to treat conditions that affect the heart or blood vessels. These conditions include heart stroke, coronary artery diseases, valvular diseases, peripheral venous diseases, pericarditis, endocarditis, cardiac tumors, arteriosclerosis, and lymphatic diseases. Some of the major cardiovascular drugs include anti-hypertensive drugs such as calcium channel blockers and Angiotensin II receptor antagonists, and hypolipidemic drugs such as fibric acid derivatives and bile acid binding resins.
The top five companies covered are Merck & Co., Sanofi S.A., Pfizer Inc., Bristol-Myers Squibb Company and Novartis AG. Merck & Co. was the largest company in the cardiovascular drugs market in 2017.
The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.
The global cardiovascular drugs market was valued at around $129 billion in 2017. North America was the largest region in the cardiovascular drugs market in 2017, accounting for nearly 40% market share. The USA was the largest country in the market in 2017, accounting for nearly 25% market share.
The innovation of gene testing technologies for the development of personalized medicine for cardiovascular diseases is one of the major trends in the market. Due to the reduction in the cost of gene testing, patients can screen for their predisposition for specific cardiovascular diseases. Gene testing helps in the development of personalized pharmacogenomic agents and improved patient monitoring efforts for cardiovascular disorders and detect them before an onset of acute care episodes.
Minor Orthopedic Replacement Implants Global Market Exceeds $1.5 Billion
Minor orthopedic implant market to be worth $2.2 billion by 2021, analysts say
Organs-on-Chips to Revolutionize the Drug Development Industry
Russia’s Musculoskeletal Drugs Market Is Catching Up With The Rest Of Europe
The Fastest Growing Regions for Dermatological Drug Sales Are the Middle East and South America
Growth of Middle Class Is Causing Heart Drugs Market In Asia Pacific To Accelerate, Says TBRC
8% Growth in Asia Pacific Presents Pharma Investors with Good Opportunities
Increasing Global Obesity And Stress Levels Mean Rapid Growth To Continue For Musculoskeletal Drugs Market
Blood Glucose Test Strips Global Market Report 2018
Veterinary Services Global Market Report 2018
Podiatry Services Global Market Strategies and Opportunities to 2021
Minor Orthopedic Implants Replacement Global Market Opportunities And Strategies To 2021
Biologics Global Market Opportunities And Strategies To 2021
Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021
Blood Glucose Test Strips Global Market Opportunities And Strategies To 2021
Veterinary Serices Global Market Opportunities And Strategies To 2021